INON ACE Antacid tablets — Class II drug recall D-0298-2026
Ongoing recall by Sato Pharmaceutical Co., Ltd, reported 2026-02-04, distributed in CA, HI. Failed Disintegration Specifications: above the time expected.
| Recall number | D-0298-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sato Pharmaceutical Co., Ltd, Tokyo, N/A, Japan |
| Recall initiated | 2025-12-19 |
| Classified | 2026-01-27 |
| Reported by FDA | 2026-02-04 |
| Distributed | CA, HI |
| Quantity | 3,640 bottles |
| NDC | 49873-0402, 49873-0402-01 |
| Expiration dates | 2027-01-31 |
Product
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
Reason for recall
Failed Disintegration Specifications: above the time expected.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0298-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.